seed
Stage
2
Investors
About
Umecrine Cognition develops novel drugs targeting GABAA receptor-modulating steroid antagonists to treat cognitive and neurological disorders caused by overactivation of these receptors.
Explore Umecrine Cognition's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.